Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
ANGLE plc ( (GB:CLBX) ) has shared an update.
CelLBxHealth plc has announced its intention to raise approximately £6 million to extend its cash runway into early 2026. The company is in discussions with shareholders and plans to make an offer to retail investors alongside an institutional placing, with an announcement expected by early December. This fundraising effort is crucial for maintaining its operations and continuing its strategic initiatives in the CTC intelligence industry.
The most recent analyst rating on (GB:CLBX) stock is a Hold with a £2.00 price target. To see the full list of analyst forecasts on ANGLE plc stock, see the GB:CLBX Stock Forecast page.
Spark’s Take on GB:CLBX Stock
According to Spark, TipRanks’ AI Analyst, GB:CLBX is a Neutral.
ANGLE plc’s overall stock score is primarily impacted by its financial performance and technical analysis, both of which highlight significant challenges. The negative financial metrics and bearish technical indicators are major concerns. While the earnings call provided some positive developments, the need for additional funding and revenue decline remain critical issues.
To see Spark’s full report on GB:CLBX stock, click here.
More about ANGLE plc
CelLBxHealth plc is a global leader in precision circulating tumour cell (CTC) intelligence, specializing in innovative CTC solutions for research, drug development, and clinical oncology. Their patent-protected Parsortix® platform is designed to harvest CTCs from blood, integrating with existing laboratory instruments for comprehensive analysis, including whole-cell imaging, proteomic profiling, and genomic workflows. The company focuses on product sales, lab-developed tests, and laboratory services, with commercial activities centered around accelerating the adoption of the Parsortix platform and providing clinical trial support.
Average Trading Volume: 2,609,998
Technical Sentiment Signal: Sell
Current Market Cap: £6.77M
Find detailed analytics on CLBX stock on TipRanks’ Stock Analysis page.